Log In
Copyright © 2006 American Chemical Society
April 17, 2006 Cover
Volume 84, Issue 16
Volume 84, Issue 16
OLIGONUCLEOTIDES
Long the target of skepticism, oligonucleotide-based antisense drugs are starting to regain favor with investors
Credit: Isis Pharmaceuticals
» Full Article
April 17, 2006 Issue
Volume 84, Issue 16
April 17, 2006 Issue, Vol. 84 | Iss. 16
Long the target of skepticism, oligonucleotide-based antisense drugs are starting to regain favor with investors
(pp. 13-18)
Features
Science & Technology
Computational method leads to library of enzymes that fold and function (p.7)
Government & Policy
Russia, even U.S., is not likely to destroy arsenals completely by 2012 as mandated by treaty (pp. 27-30)
News of the Week
Artificial P450 Enzymes Created
Computational method leads to library of enzymes that fold and function
(p.7)Energy Advisory Board Abolished
Bodman decides board is no longer needed as White House sets direction for research
(p.8)Sticky Bacterium
Chemistry behind biological adhesives super strength remains unknown
(p.8)Modern Pioneers
Biotech companies challenged at BIO meeting to contribute to global issues
(p.9)Lonza Boosts China Presence
Swiss company plans to make active pharmaceutical ingredients
(p.10)Platinum From Breast Implants
Study implicates silicone implants as source of harmful platinum species
(p.11)Treating VX
Activists, stakeholders oppose Army plan to ship, treat, and dispose of VX wastewater
(p.11)Departments
Business
Chemicals beat major indexes, while biotech and pharmaceutical shares lag behind
(pp. 21-22)
Even as costs surge for India's fine chemicals and pharmaceutical companies, managers remain bullish
(pp. 24-25)
Long the target of skepticism, oligonucleotide-based antisense drugs are starting to regain favor with investors
(pp. 13-18)Concentrates
(pp. 19-20)
(pp. 19-20)- Mitsubishi boosts polycarbonate
- Syngenta starts venture fund
- BP expanding PTA output
- Asahi Glass adds protein plant
- Bayer lights up
- Serono to stay independent
- Ciba acquires and collaborates
- Isis gets drug funding
- Lanxess invests at home
- Chemical employment up in March
- Total outlines Arkema plan
- Dow, Rompetrol in pact
- Arkema boosts capacity
- Mosaic secures ammonia
- Business Roundup
ACS News
Awards(p.45)
(p.45)- Catalysis Award Goes To Delgass
- Grad Students Win Awards In Germany
- Call For Nominations For Spencer Award
- Nominations Sought For Nichols Medal
- Applicants For Organic Graduate Fellowships
- CINF-IO Scholarship Winners Announced
- Andrew Ouderkirk Recipient Of Minnesota Award
- U.S.-China Young Scholars Program
- Chemvention Competition Winners
- National Chemistry Week Poster Contest Winners
- Cross-Disciplinary Fellowships
Government & Policy
Russia, even U.S., is not likely to destroy arsenals completely by 2012 as mandated by treaty
(pp. 27-30)
Database finds diverse themes and predominantly basic research in federally funded R&D
(p.31)
Agency cuts science programs in order to refocus funding on space exploration
(p.32)
Science & Technology
Gelatin has largely replaced the spongy confection's namesake, a plant-root ingredient
(p.41)
New and Notable in the Chemical Industry
(p.45)
Meeting spotlights novel electronic materials, antibiotic coatings, and an antiaging skin cream
(pp. 34-36)
Scientists aim to design and produce safe, high-performance nanomaterials 'right the first time'
(pp. 37-38)
An inexpensive water treatment technology is making a difference in poor communities around the world
(pp. 39-40)Career & Employment
In the interdisciplinary field, researchers are defined more by their mind-sets than skill sets
(pp. 47-49)Newscripts
Editor's Page
Most popular
Viewed
Commented
Chemistry Job Listings